CBD Guangzhou 2025 Wraps Up with International Attendance Rising by 47.22%
GUANGZHOU, China, July 27, 2025 /PRNewswire/ — The 27th China (Guangzhou) International Building Decoration Fair (CBD Fair Guangzhou), held in tandem with the Guangzhou International Bath & Sanitary Ware Fair (CBS Fair), concluded on July 11. Spanning 300,000 square meters, the fair hosted nearly 2,000 exhibitors and over 70 high-level forums and conferences. A total […]
The clock is ticking on solar tax credits and All Energy Solar can help
MADISON, Wis., July 27, 2025 /PRNewswire/ — Homeowners and businesses have a critical, rapidly approaching deadline to take advantage of the 30% federal solar tax credit: December 31, 2025. After this date, the Residential Clean Energy Credit will be eliminated entirely, and the Clean Energy Investment Tax Credit for commercial projects will be subject to new […]
Hengrui Pharma and GSK enter agreements to develop up to 12 innovative medicines across Respiratory, Immunology & Inflammation and Oncology
Includes license for potential best-in-class PDE3/4 inhibitor (HRS-9821) in clinical development for treatment of COPD Additional 11 programmes to be developed by Hengrui Pharma and optioned by GSK following phase I completion JIANGSU, China, July 27, 2025 /PRNewswire/ — Hengrui Pharma (600276.SH; 01276.HK) today announced it has entered into agreements with GSK plc (LSE/NYSE: GSK) […]
Hims & Hers Health, Inc. Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds HIMS Investors of Important Lead Plaintiff Deadline on August 25, 2025
RADNOR, Pa., July 27, 2025 /PRNewswire/ — The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that securities class action lawsuits have been filed in the United States District Court for the Northern District of California against Hims & Hers Health, Inc. (“Hims & Hers”) (NYSE: HIMS) on behalf of those who purchased or […]
Ascletis Announces First Participants with Obesity or Overweight Dosed in Its U.S. 12-week Phase IIa Study Evaluating Once-Monthly Subcutaneous Depot Formulation of Small Molecule GLP-1R Agonist ASC30
– First participants with obesity or overweight with at least one weight-related comorbidity have been dosed in a U.S. 12-week Phase IIa study with once-monthly subcutaneous (SQ) depot formulation of small molecule GLP-1 receptor agonist ASC30. – Ultra-long-acting SQ depot formulation of small molecule ASC30 demonstrated a 36-day half-life in participants with […]
Harbour BioMed Announces Positive Profit Alert for 2025 Interim Results
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, July 27, 2025 /PRNewswire/ — Harbour BioMed (the “Company”; HKEX: 02142), a global biopharmaceutical company focused on the discovery and development of novel antibody therapeutics in immunology and oncology, today announced a positive profit alert for the six months ended June 30, 2025 (the “Reporting Period”). Based on a preliminary […]
Automate Unveils Push PRO: The Smartest Remote Control for Your Shades
STAMFORD, Conn., July 27, 2025 /PRNewswire/ — Automate, a leader in smart shading solutions, proudly announces the launch of Push PRO, its first smart remote for shades with built in offline automation. Push PRO delivers a seamless and intuitive way to control motorized shades, offering advanced automation features without requiring an internet connection. Continue Reading […]
JBO Thailand Launches Esports World Cup Promotion with Rewards Up to 30,000 Jcoin
BANGKOK, July 27, 2025 /PRNewswire/ — JBO, a well-established online gaming and entertainment platform, is pleased to announce an exciting new promotion tailored for the highly anticipated Esports World Cup 2025. Esports enthusiasts in Thailand now have a compelling opportunity to win up to 30,000 Jcoin by placing wagers on the thrilling “World Cup Qualifiers” matches. […]
Elpis Biopharmaceuticals Signs Memorandum of Understanding with National Cancer Centre Singapore to Conduct Translational Cell Therapy Research in Singapore
Collaboration focuses on advancing clinically validated armored CAR technologies into first-in-human trials in Singapore and accelerate translational research from bench-to-bedside SINGAPORE and LEXINGTON, Mass., July 27, 2025 /PRNewswire/ — Elpis Biopharmaceuticals, a clinical-stage cell therapy company developing bispecific armored CAR-T therapies for solid tumors, today announced the signing of a Memorandum of Understanding (MOU) with […]
CNC Investors with Losses Have Opportunity to Lead Centene Corporation Securities Fraud Lawsuit
NEW YORK, July 27, 2025 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Centene Corporation (NYSE: CNC) between December 12, 2024 and June 30, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has […]